Colmatek
Stopping severe bleeding is crucial in trauma, war, and surgery. We being scientists and experts in biotech have developed a new hemostatic agent that outperforms current options. It not only stops bleeding effectively but also promotes wound healing. After extensive lab tests and pre-clinical trials, we've launched ColMatEk to bring this patented technology to the market.
Industries
biotechnology
health-care
medical-device
Nr. of Employees
small (1-50)